Metabolic obesity in normal body weight. Unsolved issues of diagnostics
pdf (Українська)

Keywords

type 2 diabetes with normal body weight; waist circumference; percentage of adipose and muscular tissue.

How to Cite

Goncharova, O., Partshaladze, V., & Il’ina, I. (2013). Metabolic obesity in normal body weight. Unsolved issues of diagnostics. Endokrynologia, 18(4), 50-54. Retrieved from https://endokrynologia.com.ua/index.php/journal/article/view/362

Abstract

The authors have demonstrated that in a cohort with normal body weight (normBW) and type 2 diabetes mellitus (DM) anthropometric signs of metabolic obesity are significantly more common than in those without DM. This suggests that these signs, being available for determination in everyday medical practice, may be used not only as diagnostic, but also as prognostic methods. An increased waist circumference (WC) that is considered by IDF to be the
main criterion for diagnosis of metabolic syndrome, was reported in 58.8 % of patients with type 2 DM and in 24.0% among those without diabetes. An increased WC/growth ratio, whose advantage is an equal normal index for men and women, occurred in 52.9 % of type 2 DM cases and in 11,8% of control cases. At the same time, an increased percentage of adipose tissue (AT) in the presence of type 2 DM was reported in 94.1 % of cases versus 52.0 % in those without diabetes. To some extent, this difference in the frequency of these indices can be due to an inadequacy of normal WC standards for persons with
normBW, which are not able to reveal in many cases the presence of abdominal obesity. On the other hand, it should be noted that the level of AT percentage includes not only a visceral component.

pdf (Українська)

References

1. Romero-Corral A., Somers V.K., Sierra-Johnson J. et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality // Eur. Heart J. 2010, 31, N 6, 737-746.
2. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome – a new world-wide definition. Consensus statement from the International Diabetes Federation // Diabet. Med. 2006, 23, 469-480.
3. МітченкоО.І. Патогенетичні основи метаболічного синдрому // Нова медицина. 2004, № 4, 20-24. (Mitchenko O.I. Pathogenetic fundamentals of metabolic
syndrome // New Medicine. 2004, N 4, 20-24).
4. Grundy S.M. Does a diagnosis of metabolic syndrome have a value in clinical practice? // Am. J. Clin. Nutr. 2006, 83, 1248-1251.
5. Hsieh S.D., Yoshinaga H., Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and
women // Int. J. Obes. 2003, 27, 610-616.
6. Mombelli G., Zanaboni A.M., Gaito D.S. et al. Waist-toheight ratio is a highly sensitive index for the metabolic syndrome in a mediterranean population // Metab. Syndr. Relat. Disord. 2009, 7, N 5, 477-484.
7. Meseri R., Ucku R., Unal B. Waist:height ratio: a superior index in estimating cardiovascular risks in Turkish adults // Pub. Health Nutr. 2013,1-7.
8. Kahn R., Buse J., Ferrannini E. et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. // Diabetes Care. 2005, 38, 2289-2304.
9. Sonmez K., Akcakoyun M., Akcay A. et al. Which method should be used to determine the obesity, in patients with coronary artery disease? (body mass index, waist circumference or waist-height ratio) // Int. J. Obes. Relat. Metab. Disord. 2003; 27(3):341-346.
10. Inzucchi S.E., Bergenstal R.M., Buse J.B. et al. Management of Hyperglycemia in type 2 diabetes: a patient-centered approach //Diab. Care 2012, 1-16 (publ.
ahead of print).
11. Klaus J.R., Hurwitz B.E., Llabre M.M. et al. Central obesity and insulin resistance in the cardiometaцbolic syndrome: pathways to preclinical cardiovascular structure and function // J. CardioMetabolic Syndr. 2009, 4, N 2, 63-71.

Downloads

Download data is not yet available.